购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • IL Receptor
    (1)
  • NF-κB
    (1)
  • Parasite
    (1)
  • TNF
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 5日内发货
    (10)
  • 20日内发货
    (4)
  • 6-8周
    (1)
筛选
搜索结果
TargetMol产品目录中 "

interleukin-1beta

"的结果
  • 抑制剂&激动剂
    5
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    12
    TargetMol | Recombinant_Protein
  • 多肽产品
    1
    TargetMol | Peptide_Products
  • 天然产物
    1
    TargetMol | Natural_Products
  • 检测抗体
    2
    TargetMol | Antibody_Products
  • Interleukin 1beta
    T21048117027-34-6
    Interleukin 1beta is a bioactive chemical.
    • 待询
    规格
    数量
  • Interleukin 1beta acetate(117027-34-6 Free base)
    T21048L
    Interleukin 1beta acetate(117027-34-6 Free base) 在生命科学相关研究中具有广泛的应用。
      询价
    • Menthone
      薄荷酮
      T566010458-14-7
      Menthone 是一种从植物和薄荷油中提取的单萜,是精油的主要挥发性成分,具有抗炎和抗氧化特性。
      • ¥ 192
      现货
      规格
      数量
    • U 27391
      U-27391,U27391
      T26304106314-87-8
      U 27391 is a metalloproteinase inhibitor. It acts by inhibits the action of human recombinant interleukin-1beta and glycosaminoglycan synthesis.
      • ¥ 10600
      6-8周
      规格
      数量
    • R-130823
      T69451321344-32-5
      R-130823 is a ighly selective inhibition against mitogen-activated protein kinase p38alpha (IC50=22 nM). The release of tumor necrosis factor-alpha, interleukin-1beta, -6 and -8 was inhibited in lipopolysaccharide-stimulated human blood pretreated by R-130823 , with IC50 values of 0.089, 0.066, 0.95 and 0.16 microM, respectively. R-130823 reduced the established hind paw swelling in rat adjuvant-induced arthritis, while methotrexate showed no suppression. In the same model, R-130823 ameliorated adjuvant-induced hyperalgesia with rapid onset and long duration comparable to a cyclooxygenase-2 inhibitor, celecoxib.
      • ¥ 15000
      8-10周
      规格
      数量